Lapinig, Magdalena B.
HRN: 26-83-95 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
CEFUROXIME 1.5GM (VIAL)
05/22/2025
05/29/2025
IV
1.5 Grams
Q8
SP 1LTCS
Waiting Final Action
05/25/2025
CEFUROXIME 500MG (TAB)
05/25/2025
05/30/2025
PO
500mg
BID
SP CS
Waiting Final Action